Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Tuulia Vallius, M.D., Ph.D.

Concepts (69)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Neoplasms, Glandular and Epithelial320174871.140 Why?
Ovarian Neoplasms5201948780.570 Why?
CA-125 Antigen220172810.510 Why?
Fluorodeoxyglucose F183201820090.430 Why?
Tumor Burden1201818920.390 Why?
Proteins2201760320.360 Why?
Neoadjuvant Therapy2201828280.330 Why?
Radiopharmaceuticals2201726500.330 Why?
Single-Cell Analysis2202424510.210 Why?
Antineoplastic Combined Chemotherapy Protocols32020117420.200 Why?
Quality Control120248320.190 Why?
Software2202444340.170 Why?
Chemotherapy, Adjuvant3202035140.160 Why?
Pyrimidinones120203850.150 Why?
Organoplatinum Compounds220184070.150 Why?
Cisplatin2202016520.140 Why?
Receptors, Progesterone1202111290.130 Why?
Artifacts1202419110.130 Why?
Tumor Microenvironment2202438780.110 Why?
Receptors, Estrogen1202122090.100 Why?
Neoplasm Staging22017111200.090 Why?
Receptor, erbB-21202125570.090 Why?
Image Processing, Computer-Assisted2202490010.090 Why?
Positron-Emission Tomography2201864840.090 Why?
Postoperative Care1201714680.090 Why?
Pyrazoles1202020090.090 Why?
Cystadenocarcinoma, Serous120144780.090 Why?
Drug Resistance, Neoplasm2201953050.070 Why?
Regression Analysis1201563450.060 Why?
Prognosis22018296290.060 Why?
Aged, 80 and over32018589840.060 Why?
Research Design1201961800.060 Why?
Melanoma1202257090.050 Why?
Tomography, X-Ray Computed22018205680.050 Why?
Skin Neoplasms1202258210.050 Why?
Aged520201693100.050 Why?
Female820213927050.050 Why?
Models, Statistical1201550790.050 Why?
Membrane Proteins1201778590.040 Why?
Humans1220247615960.040 Why?
Platinum120192200.040 Why?
Retrospective Studies22018806470.040 Why?
Ecosystem120224900.040 Why?
Reproducibility of Results12015201000.040 Why?
Mammals1202211320.040 Why?
Models, Theoretical2201935750.030 Why?
Middle Aged420202209210.030 Why?
Prospective Studies22018544230.030 Why?
Taxoids120196680.030 Why?
Lymphocytes, Tumor-Infiltrating1202110920.030 Why?
Antineoplastic Agents12018136420.030 Why?
Cohort Studies12017414950.030 Why?
Cell Nucleus1202229100.030 Why?
Breast Neoplasms12021210190.030 Why?
Follow-Up Studies12014391060.030 Why?
Drug Combinations1201820480.020 Why?
Computational Biology1202435170.020 Why?
Protein-Tyrosine Kinases1202024250.020 Why?
Cell Cycle Proteins1202034490.020 Why?
Kaplan-Meier Estimate1201964840.020 Why?
Adult320202212100.020 Why?
Treatment Outcome12014646850.020 Why?
Cytokines1202273960.020 Why?
Computer Simulation1201962410.020 Why?
Clinical Trials as Topic1201980020.010 Why?
Apoptosis1201994900.010 Why?
Animals220241684750.010 Why?
Neoplasms12024221730.010 Why?
Young Adult12020592600.010 Why?
Vallius's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (69)
Explore
_
Co-Authors (27)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.